Metformin added to intensive insulin therapy reduces plasma levels of glycated but not oxidized low‑density lipoprotein in young patients with type 1 diabetes and obesity in comparison with insulin alone: a pilot study
Open accessThe DOI matches its Crossref record.
Abstract
INTRODUCTION: There are scarce data about the effect of metformin on lipid profile in patients with type 1 diabetes. OBJECTIVES: The present study is the first prospective clinical trial evaluating the effect of combined therapy of metformin and insulin on the pool of oxidized and glycated low‑density lipoproteins (LDL) in young patients with type 1 diabetes and concomitant obesity. PATIENTS AND METHODS: A total of 33 obese patients with type 1 diabetes treated with intensive insulin therapy were randomized into a group where metformin was added. The remaining 19 patients continued to receive intensive insulin therapy (control group). In all patients, lipid profile and glycemia were assessed using routine laboratory tests. Oxidized and glycated LDL were measured using commercially available kits. Laboratory tests were performed at baseline and at a control visit after 6 months of treatment. RESULTS: A significant decrease in the levels of glycated hemoglobin, fasting plasma glucose, postprandial glucose, average glucose, triglycerides, glycated LDL, and body mass index was observed in the group receiving combined therapy. A similar decrease was not observed in the control group. The remaining lipid parameters were not changed during follow‑up in any of the groups. CONCLUSIONS: Addition of metformin to intensive insulin therapy in young obese patients with type 1 diabetes results in a significant reduction of glycated LDL levels. This can be possibly explained by better glucose control, which improved insulin sensitivity of the peripheral tissues and reduced body mass in this patient group.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Obesity and diabetes—Not only a simple link between two epidemics
Chobot, A., Górowska‐Kowolik, K., Sokołowska, M., & Jarosz‐Chobot, P. (2018) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3042 · Cited by 281
Obesity, insulin resistance, and type 1 diabetes mellitus
Polsky, S., & Ellis, S. L. (2015) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0000000000000170 · Cited by 235
“Changes in the lipid profile and BMI were thought to result from both improved glycemic control and increased tissue insulin sensitivity induced by metformin therapy [22].”
BackgroundInfluentialWeight management in patients with type 1 diabetes and obesity
Mottalib, A., Kasetty, M., Mar, J. Y., Elseaidy, T., Ashrafzadeh, S., & Hamdy, O. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0918-8 · Cited by 149
Bariatric surgery in obese patients with type 1 diabetes
Kirwan, J. P., Aminian, A., Kashyap, S. R., Burguera, B., Brethauer, S. A., & Schauer, P. R. (2016) · Diabetes Care · doi:10.2337/dc15-2732 · Cited by 80
“Some studies have shown that adding metformin (15,16),”
BackgroundLiu, Y., Chen, C., Chen, Z., Peng, Y., Lin, X., & Xu, L. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3334 · Cited by 36
Metadata
- Authors
- Burchardt, P., Zawada, A., Tabaczewski, P., Naskręt, D., Kaczmarek, J., Marcinkaniec, J., Wierusz‑Wysocka, B., & Wysocki, H.
- Venue
- Polish Archives of Internal Medicine
- Publisher
- Medycyna Praktyczna
- Published
- 2013-08-08
- Volume
- 123
- Issue
- 10
- Pages
- 526-532
- ISSN
- 0032-3772 (ISSN-L)
- 1897-9483
- OpenAlex
- W2338869610
- Cited by
- 28
- References
- 0
- FWCI
- 1.42
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Metformin added to intensive insulin therapy reduces plasma levels of glycated but not oxidized low‑density lipoprotein in young patients with type 1 diabetes and obesity in comparison with insulin alone: a pilot study. https://app.cochat.ai/papers/10.20452/pamw.1925
- The paper
- Burchardt, P., Zawada, A., Tabaczewski, P., Naskręt, D., Kaczmarek, J., Marcinkaniec, J., Wierusz‑Wysocka, B., & Wysocki, H. (2013). Metformin added to intensive insulin therapy reduces plasma levels of glycated but not oxidized low‑density lipoprotein in young patients with type 1 diabetes and obesity in comparison with insulin alone: a pilot study. Polish Archives of Internal Medicine. https://doi.org/10.20452/pamw.1925
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.